Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell tags : Solid tumors save search
Biomea Fusion Announces Upcoming Presentations of Preclinical Data in Diffuse Large B-Cell Lymphoma, Multiple Myeloma, and Several KRAS Mutant Solid Tumors for BMF-219 at AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - globenewswire.com
BMEA | $10.87 -2.6% -2.67% 1.3M
|
Professional, Scientific, and T...
|
| O: 3.25%
H: 4.04%
C: 2.25%
bmf-219 solid tumors presentation cel preclinical t-cell pre-clinical
Atara Biotherapeutics Announces Preliminary Results for ATA2271, a Next-Generation Autologous Mesothelin-targeted CAR T-cell Therapy for Solid Tumors, at ESMO Immuno-Oncology Congress 2021
Published: 2021-12-09 (Crawled : 14:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: -2.59%
H: 1.04%
C: -5.89%
ata2271 solid tumors therapeutics therapy results iot t-cell
Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Product Candidate Targeting Mesothelin to Treat Solid Tumors at the Annual Meeting of the Society for Immunotherapy of Cancer
Published: 2021-11-12 (Crawled : 13:15) - globenewswire.com
CLLS | $2.47 0.4% 12K
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
immunotherapy solid tumors therapy car-t cancer ucartmeso preclinical t-cell pre-clinical
Nurix Therapeutics Announces IND clearance for DeTIL-0255, a drug-enhanced autologous T cell therapy for the potential treatment of a variety of solid tumors
Published: 2021-11-12 (Crawled : 13:00) - biospace.com/
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: -1.54%
H: 0.0%
C: 0.0%
treatment solid tumors potential therapy drug clearance t-cell
IN8bio to Present Preclinical Data on the Potential for Gamma-Delta T-cell Therapy Combinations with PARP and Checkpoint Inhibitors in Solid Tumors
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
INAB | $1.0 -4.76% -5.0% 280K
|
|
| O: -3.04%
H: 7.24%
C: -1.81%
solid tumors potential therapy t-cell preclinical pre-clinical
Imugene and Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic Virus - Allogeneic CAR T-Cell Immunotherapy Combination for the Treatment of Solid Tumors
Published: 2021-08-04 (Crawled : 00:00) - globenewswire.com
CELU | News F | $3.09 -3.74% -3.88% 24K
|
|
| O: 0.35%
H: 3.9%
C: -8.05%
treatment partnership immunotherapy solid tumors therapy t-cell car-t
Kiromic Announces Identification of Novel Targets for Allogeneic CAR Gamma Delta T-cell Therapy in Solid Tumors Utilizing Kiromic’s Proprietary Artificial Intelligence Engine
Published: 2021-05-21 (Crawled : 13:00) - biospace.com/
KRBP | $2.5 -90.21% 830
|
Health Technology
|
| O: 1.87%
H: 0.72%
C: -2.6%
artificial intelligence solid tumors therapy t-cell
Kiromic to Resubmit Two Expanded INDs to the FDA for Its Allogenic, Off-the-Shelf Gamma-Delta T cell Therapies for Multiple Solid Tumors
Published: 2021-03-09 (Crawled : 23:02) - biospace.com/
KRBP | $2.5 -90.21% 830
|
Health Technology
|
| O: 0.55%
H: 11.19%
C: 8.35%
fda therapy t-cell solid tumors